Evolution Wealth Advisors, LLC Takeda Pharmaceutical CO LTD Transaction History

Evolution Wealth Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$13.17 - $16.4 $3,648 - $4,542	-277 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$16.3 - $17.26 $9,372 - $9,924	-575 Reduced 67.49%	277 $5,000
Q2 2021 Jul 22, 2021	SELL	$16.55 - $18.64 $3,392 - $3,821	-205 Reduced 19.39%	852 $14,000
Q4 2020 Feb 02, 2021	SELL	$15.39 - $18.97 $4,986 - $6,146	-324 Reduced 23.46%	1,057 $19,000
Q3 2020 Oct 15, 2020	SELL	$17.1 - $19.19 $4,223 - $4,739	-247 Reduced 15.17%	1,381 $25,000

Q2 2020 Jul 27, 2020	SELL	$14.59 - $19.5 $919 - $1,228	-63 Reduced 3.73%	1,628 $29,000
Q1 2020 Apr 22, 2020	SELL	$13.02 - $20.31 $10,611 - $16,552	-815 Reduced 32.52%	1,691 $26,000
Q4 2019 Feb 03, 2020	BUY	$16.88 - $20.83 $38,266 - $47,221	2,267 Added 948.54%	2,506 $49,000
Q3 2019 Nov 12, 2019	SELL	$16.15 - $17.99 $38,307 - $42,672	-2,372 Reduced 90.85%	239 $4,000
Q2 2019 Jul 12, 2019	BUY	$16.58 - $20.49 $43,290 - $53,499	2,611 New	2,611 $46,000

340

76.2M

1.85M

121K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Evolution Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Evolution Wealth Advisors, LLC with notifications on news.